Skip to main content

Find Clinical Trials

Home
Conditions
Paraproteinemias

Clinical trial condition

Paraproteinemias

Explore clinical trials studying Paraproteinemias. Study availability and eligibility vary by location and protocol.

3,043 public trials 577 recruiting studies

Refine in advanced search Browse all conditions

Paraproteinemias trial results

Suspended

Testing the Combination of Two Approved Drugs and One Experimental Drug in Patients With Relapsed or Refractory Multiple Myeloma

NCT06232044

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: Mary Greeley Medical Center Ames, Iowa, United States

McFarland Clinic - Ames Ames, Iowa, United States

McFarland Clinic - Boone Boone, Iowa, United States

McFarland Clinic - Trinity Cancer Center Fort Dodge, Iowa, United States

View all 43 locations

View Trial Details

Suspended

Telemedicine-mHealth Symptom Cluster Intervention for Advanced Cancer Patients: Finding Our Center Under Stress (FOCUS)

NCT07102212

Conditions: Alzheimer Disease, Anxiety Disorders, Behavior, +56 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Withdrawn

²¹¹At-OKT10-B10 and Fludarabine Alone or in Combination With Cyclophosphamide and Low-Dose TBI Before Donor Stem Cell Transplant for the Treatment of Newly Diagnosed, Recurrent, or Refractory High-Risk Multiple Myeloma

NCT04579523

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details